DK0600010T3 - Use of relaxin for the manufacture of a medicament for the treatment of cardiovascular diseases - Google Patents

Use of relaxin for the manufacture of a medicament for the treatment of cardiovascular diseases

Info

Publication number
DK0600010T3
DK0600010T3 DK92918862T DK92918862T DK0600010T3 DK 0600010 T3 DK0600010 T3 DK 0600010T3 DK 92918862 T DK92918862 T DK 92918862T DK 92918862 T DK92918862 T DK 92918862T DK 0600010 T3 DK0600010 T3 DK 0600010T3
Authority
DK
Denmark
Prior art keywords
relaxin
treatment
medicament
manufacture
cardiovascular diseases
Prior art date
Application number
DK92918862T
Other languages
Danish (da)
Inventor
Michael Cronin
Phyllis L Osheroff
G Roger Thomas
David G Ward
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/747,080 external-priority patent/US5166191A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0600010T3 publication Critical patent/DK0600010T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention concerns the use of relaxin or another compound capable of specific binding of a relaxin receptor in the heart in the cardiovascular therapy, and specifically in the treatment of acute and chronic heart failure or of a condition characterized by pathologically low heart rate. The invention further concerns the treatment of neurodegenerative diseases using relaxin or other compounds capable of selectively binding a relaxin receptor in the brain.
DK92918862T 1991-08-19 1992-08-18 Use of relaxin for the manufacture of a medicament for the treatment of cardiovascular diseases DK0600010T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/747,080 US5166191A (en) 1991-08-19 1991-08-19 Use of relaxin in cardiovascular therapy
US07/902,637 US5478807A (en) 1991-08-19 1992-06-23 Use of relaxin in the treatment of bradycardia
PCT/US1992/006927 WO1993003755A2 (en) 1991-08-19 1992-08-18 Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
DK0600010T3 true DK0600010T3 (en) 2002-07-01

Family

ID=27114692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92918862T DK0600010T3 (en) 1991-08-19 1992-08-18 Use of relaxin for the manufacture of a medicament for the treatment of cardiovascular diseases

Country Status (11)

Country Link
US (1) US5478807A (en)
EP (1) EP0600010B1 (en)
JP (1) JP3747058B2 (en)
AT (1) ATE214287T1 (en)
AU (1) AU662923B2 (en)
CA (1) CA2114250C (en)
DE (1) DE69232485T2 (en)
DK (1) DK0600010T3 (en)
ES (1) ES2173868T3 (en)
NZ (1) NZ243970A (en)
WO (1) WO1993003755A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0675732B1 (en) * 1993-07-27 2006-06-28 Mario Bigazzi Use of relaxin in the manufacture of therapeutic agents
US7069634B1 (en) 1995-04-28 2006-07-04 Medtronic, Inc. Method for manufacturing a catheter
US5911997A (en) * 1995-06-07 1999-06-15 Connetics Corporation Relaxin-like factor and methods and uses thereof
US5811395A (en) 1995-06-07 1998-09-22 Medical University Of South Carolina Relaxin analogs and derivatives methods and uses thereof
JP4568383B2 (en) * 1995-08-15 2010-10-27 コルセラ，インコーポレイティッド Method for promoting angiogenesis
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
US5846220A (en) * 1996-04-30 1998-12-08 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US7189222B2 (en) 1996-04-30 2007-03-13 Medtronic, Inc. Therapeutic method of treatment of alzheimer's disease
US6627746B1 (en) 1998-04-17 2003-09-30 Exelixis, Inc. Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof
US6251863B1 (en) * 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
US6308095B1 (en) 1999-02-12 2001-10-23 Cardiac Pacemakers, Inc. System and method for arrhythmia discrimination
US6266554B1 (en) 1999-02-12 2001-07-24 Cardiac Pacemakers, Inc. System and method for classifying cardiac complexes
US6223078B1 (en) 1999-03-12 2001-04-24 Cardiac Pacemakers, Inc. Discrimination of supraventricular tachycardia and ventricular tachycardia events
US6312388B1 (en) * 1999-03-12 2001-11-06 Cardiac Pacemakers, Inc. Method and system for verifying the integrity of normal sinus rhythm templates
US6449503B1 (en) 1999-07-14 2002-09-10 Cardiac Pacemakers, Inc. Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm
US6684100B1 (en) 2000-10-31 2004-01-27 Cardiac Pacemakers, Inc. Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification
DE10155843A1 (en) * 2000-11-16 2003-01-30 Immundiagnostik Ag Procedure for the prognosis and diagnosis of heart failure
US20040006205A1 (en) * 2001-04-03 2004-01-08 Li Li Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6526313B2 (en) 2001-06-05 2003-02-25 Cardiac Pacemakers, Inc. System and method for classifying cardiac depolarization complexes with multi-dimensional correlation
AUPR814401A0 (en) 2001-10-08 2001-11-01 Howard Florey Institute Of Experimental Physiology And Medicine Human 3 relaxin
US6950702B2 (en) 2002-07-15 2005-09-27 Cardiac Pacemakers, Inc. Use of curvature based features for beat detection
US7792571B2 (en) 2003-06-27 2010-09-07 Cardiac Pacemakers, Inc. Tachyarrhythmia detection and discrimination based on curvature parameters
US7878978B2 (en) * 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
WO2005089489A2 (en) * 2004-03-19 2005-09-29 Bas Medical, Inc. Use of relaxin to increase arterial compliance
US7430446B2 (en) 2005-01-20 2008-09-30 Cardiac Pacemakers, Inc. Methods and apparatuses for cardiac arrhythmia classification using morphology stability
JPWO2006118131A1 (en) * 2005-04-26 2008-12-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 Peptide having anxiolytic action and screening method
US20060264367A1 (en) * 2005-05-21 2006-11-23 Howard Florey Institute Prevention of fibrosis following cardiac injury
US9314210B2 (en) 2005-06-13 2016-04-19 Cardiac Pacemakers, Inc. Method and apparatus for rate-dependent morphology-based cardiac arrhythmia classification
AU2007212110A1 (en) 2006-02-02 2007-08-16 Innovative Bio Therapies An extracorporeal cell-based therapeutic device and delivery system
GB2462221B (en) 2008-05-16 2010-09-01 Corthera Inc Administration of relaxin to reduce diuretic use in humans with acute decompensated heart failure
WO2010071692A2 (en) 2008-06-18 2010-06-24 Innovative Biotherapies, Inc. Methods for enhanced propagation of cells
US9653006B2 (en) 2008-09-17 2017-05-16 Avery Dennison Corporation Activatable adhesive, labels, and related methods
RU2552497C2 (en) 2009-09-17 2015-06-10 Авери Деннисон Корпорейшн Activated adhesives, labels and related methods
WO2024047130A1 (en) 2022-08-31 2024-03-07 Relaxera Pharmazeutische Gesellschaft mbH & Co. KG Immunosuppressive medicament and method of treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656249A (en) * 1982-06-10 1987-04-07 Howard Florey Institute Of Experimental Physiology And Medicine Peptides with relaxin activity
ATE78042T1 (en) * 1982-08-12 1992-07-15 Florey Howard Inst ANALOGUES OF HUMAN RELAXIN.
AU562962B2 (en) * 1982-08-12 1987-06-25 Howard Florey Institute Of Experimental Physiology And Medicine Molecular cloning and characterisation of the gene sequence coding for human relaxin
DE3236267A1 (en) * 1982-09-30 1984-04-05 Serono Pharmazeutische Präparate GmbH, 7800 Freiburg METHOD FOR PRODUCING RELAXIN AND METHOD FOR CLEANING RELAXIN
DE3236264A1 (en) * 1982-09-30 1984-04-05 Serono Pharmazeutische Präparate GmbH, 7800 Freiburg METHOD FOR OBTAINING RELAXIN
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin
NZ206534A (en) * 1982-12-13 1988-05-30 Florey Howard Inst Molecular cloning and characterisation of gene sequence coding for human relaxin
AU562713B2 (en) * 1982-12-13 1987-06-18 Howard Florey Institute Of Experimental Physiology And Medicine Cloning for human relaxin
US4835251A (en) * 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
DE68906153T2 (en) * 1988-02-26 1993-10-28 Genentech Inc HUMANES RELAXATION DEVICE.
CA2051375C (en) * 1989-05-04 2000-09-12 Dennis J. Henner Process and compositions for the isolation of human relaxin
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy

Also Published As

Publication number Publication date
DE69232485T2 (en) 2002-11-21
CA2114250C (en) 2007-10-16
AU662923B2 (en) 1995-09-21
JPH06510045A (en) 1994-11-10
EP0600010B1 (en) 2002-03-13
JP3747058B2 (en) 2006-02-22
WO1993003755A2 (en) 1993-03-04
CA2114250A1 (en) 1993-03-04
EP0600010A1 (en) 1994-06-08
DE69232485D1 (en) 2002-04-18
US5478807A (en) 1995-12-26
NZ243970A (en) 1997-06-24
WO1993003755A3 (en) 1993-04-01
AU2518692A (en) 1993-03-16
ATE214287T1 (en) 2002-03-15
ES2173868T3 (en) 2002-11-01

Similar Documents

Publication Publication Date Title
DK0600010T3 (en) Use of relaxin for the manufacture of a medicament for the treatment of cardiovascular diseases
NO20053105D0 (en) Oral, extended-release analgesic dosage form for administration ± once per day. day.
NO20013727D0 (en) Use of Botulinum toxin B for the preparation of a drug
UA27911C2 (en) MEANS FOR TREATMENT OR PREVENTION OF PHYSIOLOGICAL DISORDERS CAUSED BY EXCESS TAKHIKININ
MXPA03003960A (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders.
ITTO920145A0 (en) MULTIFUNCTIONAL PATIENT VALVE.
DK0659410T3 (en) Use of the active agent flupirtine in the manufacture of a drug for controlling muscle tension
KR960702318A (en) Treatment of muscle diseases and disorders
NO884259L (en) DOSAGE DEVICE FOR TREATMENT OF CARDIOVASCULAR DISEASES.
NL7903824A (en) COMPOSITION FOR THE THERAPEUTIC TREATMENT OF CHRONIC UREMIA PATIENTS WHO PERIODICALLY UNDERGO HEMODIALYSIS.
MX9202388A (en) CENTRAL VENOUS CATHETER PATIENT COVER.
DE3875675D1 (en) ASYMMETRIC S.P.E.C.T. Collimator that surrounds the patient.
DK578887A (en) antihypertensives
IT8121703A0 (en) CHAIR FOR DENTAL PRACTICE PATIENTS.
NO970573L (en) Yliden compounds and their preparation
DK0814791T3 (en) Aminotetralin derivative for the treatment of cardiovascular diseases
DK0768083T3 (en) Use of sertraline to treat patients with post myocardial infarction
DE3380923D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS.
ITMI911578A1 (en) USE OF PHOSPHATIDYLINITITOL FOR THERAPY OF DEPRESSION DISORDERS.
NO953003L (en) Use of ifenprodil and its diastereoisomers for the preparation of medical preparations
IL151878A0 (en) Pharmaceutical compositions containing t3
MY127662A (en) Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
DK0429324T3 (en) Use of N-methyl-2- (3-pyridyl) -tetrahydrothiopyran-2-carbothioamide-1-oxide in the manufacture of drugs intended to treat coronary insufficiency
IT8125670A0 (en) DENTAL CHAIR FOR PATIENTS.
WO1997004790A3 (en) Drug for use in the treatment of ulcers containing magnesium ions as active substance